Prediction and Prevention of Preeclampsia

The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring C-reactive protein levels in a biological sample of a pregnant woman. The disclosure further encompasses methods of reducing risk of preeclampsia through administration of a pharmaceutical formulation of relaxin to a pregnant woman.

Attached files:
WO 2010060102.jpg

Patents:
WO 2,010,060,102

Inventor(s): STEWART DENNIS R [US]; CONRAD KIRK P [US]; JEYABALAN ARUNDHATHI [US]

Type of Offer: Licensing



Next Patent »
« More Pharmaceutical Patents
« More Diagnostic Patents

Share on      


CrowdSell Your Patent